Skip to content

Clinical trials

Completed Phase 1/2 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 1/2 Status: Completed Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20071
20141
20151
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Bristol-Myers Squibb1
Children's Hospital of Philadelphia1
Kyowa Kirin China Pharmaceutical Co., Ltd.1
Neufeld, Ellis J, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic7
Anemia, Hemolytic2
Anemia, Hemolytic, Autoimmune2
Purpura, Thrombocytopenic2
Arthritis, Rheumatoid1
Autoimmune Lymphoproliferative Syndrome1
Cytopenia1
Inflammatory Bowel Diseases1
Lupus Erythematosus, Systemic1
Neutropenia1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.